By Christine McConville | Wednesday, January 28, 2009 | http://www.bostonherald.com | Business & Markets

The Massachusetts Life Sciences Center agreed yesterday to award a $7.4 million grant to Organogenesis Inc. to facilitate a major expansion.

The Canton-based regenerative medicine company treats diseases by using living cells to restore damaged tissues and organs.

The grant money will help the company expand its presence in Canton. The company has said that with the expanded location, the company will provide an additional 280 jobs.

Organogenesis currently employs 200 people.

Also yesterday, the Center appointed three new members to its scientific advisory board. Jonathan Fleming, managing general partner at Oxford Bioscience Partners; Doug Cole, general partner at Flagship Ventures; and Jean M. George, partner at Advanced Technology Ventures, will join the board’s 12 other members in making decisions about the Center’s scientific funding.

Article URL: http://www.bostonherald.com/business/general/view.bg?articleid=1148312

Comments

Leave a Reply

You must be logged in to post a comment.